DK169987D0 - Human tumor-associated antigen, ca-ou1 - Google Patents

Human tumor-associated antigen, ca-ou1

Info

Publication number
DK169987D0
DK169987D0 DK169987A DK169987A DK169987D0 DK 169987 D0 DK169987 D0 DK 169987D0 DK 169987 A DK169987 A DK 169987A DK 169987 A DK169987 A DK 169987A DK 169987 D0 DK169987 D0 DK 169987D0
Authority
DK
Denmark
Prior art keywords
associated antigen
human tumor
tumor
human
antigen
Prior art date
Application number
DK169987A
Other languages
Danish (da)
English (en)
Inventor
Jens Christian Jensenius
Per Borup-Christensen
Karin Erb
Original Assignee
Jens Christian Jensenius
Borup Christensen Per
Karin Erb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jens Christian Jensenius, Borup Christensen Per, Karin Erb filed Critical Jens Christian Jensenius
Priority to DK169987A priority Critical patent/DK169987D0/da
Publication of DK169987D0 publication Critical patent/DK169987D0/da
Priority to JP63503303A priority patent/JPH082920B2/ja
Priority to AU15965/88A priority patent/AU618260B2/en
Priority to DK182188A priority patent/DK162844C/da
Priority to PCT/DK1988/000059 priority patent/WO1988007377A1/en
Priority to US07/411,469 priority patent/US5338661A/en
Priority to ES88105299T priority patent/ES2059418T3/es
Priority to AT88105299T priority patent/ATE95426T1/de
Priority to IE97688A priority patent/IE60993B1/en
Priority to DE88105299T priority patent/DE3884646T2/de
Priority to EP88105299A priority patent/EP0285173B1/de
Priority to ZA882353A priority patent/ZA882353B/xx
Priority to IL8595588A priority patent/IL85955A/en
Priority to NZ224156A priority patent/NZ224156A/en
Priority to KR1019880701592A priority patent/KR890700358A/ko
Priority to NO885392A priority patent/NO176903C/no
Priority to FI894650A priority patent/FI894650A/fi
Priority to LV940022A priority patent/LV10202B/en
Priority to FI942883A priority patent/FI942883A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK169987A 1987-04-03 1987-04-03 Human tumor-associated antigen, ca-ou1 DK169987D0 (da)

Priority Applications (19)

Application Number Priority Date Filing Date Title
DK169987A DK169987D0 (da) 1987-04-03 1987-04-03 Human tumor-associated antigen, ca-ou1
JP63503303A JPH082920B2 (ja) 1987-04-03 1988-03-30 ヒト腫瘍関連抗原
AU15965/88A AU618260B2 (en) 1987-04-03 1988-03-30 Human tumour-associated antigen
DK182188A DK162844C (da) 1987-04-03 1988-03-30 Antistof mod et humant carcinom-associeret antigen, et saadant humant carcinom-associeret antigen, et anti-idiotypisk antistof rettet mod antistoffet, et anti-anti-idiotypisk antistof rettet mod det anti-idiotypiske antistof, et diagn. middel, der omfatter antistoffet eller antigenet, fremg.maade til fremstil. af et monoklonalt antistof mod et carcinom-accocieret antigen, fremg.maade til in med mere
PCT/DK1988/000059 WO1988007377A1 (en) 1987-04-03 1988-03-30 Human tumour-associated antigen
US07/411,469 US5338661A (en) 1987-04-03 1988-03-30 Monoclonal antibody specific for a human tumour-associated antigen
ZA882353A ZA882353B (en) 1987-04-03 1988-03-31 Human tumour-associated antigen
IE97688A IE60993B1 (en) 1987-04-03 1988-03-31 Human tumour-associated antigen
AT88105299T ATE95426T1 (de) 1987-04-03 1988-03-31 Humanes karcinom-assoziertes antigen und an dieses antigen bindende antikoerper.
ES88105299T ES2059418T3 (es) 1987-04-03 1988-03-31 Antigeno asociado a carcinoma humano y anticuerpo asociado al antigeno.
DE88105299T DE3884646T2 (de) 1987-04-03 1988-03-31 Humanes Karcinom-assoziertes Antigen und an dieses Antigen bindende Antikörper.
EP88105299A EP0285173B1 (de) 1987-04-03 1988-03-31 Humanes Karcinom-assoziertes Antigen und an dieses Antigen bindende Antikörper
IL8595588A IL85955A (en) 1987-04-03 1988-04-01 A cytoplasmic antigen is attributed to human cancer An antibody that binds to that antigen, a method for diagnosing human cancer in vitro, and a distant preparation or diagnostic agent that includes
NZ224156A NZ224156A (en) 1987-04-03 1988-04-06 Human cancer antigen and antibodies to it
KR1019880701592A KR890700358A (ko) 1987-04-03 1988-12-02 인체 종양관련 항원
NO885392A NO176903C (no) 1987-04-03 1988-12-02 Antistoff eller bindende fragment derav til diagnostikk av humant carcinom, eller som transportör av farmasöytiske midler, isolert, humant tumor-assosiert antigen, diagnostisk middel og fremgangsmåte for in vitro-diagnostisering
FI894650A FI894650A (fi) 1987-04-03 1989-10-02 Antigen, som associerar till en human tumoer.
LV940022A LV10202B (en) 1987-04-03 1994-01-27 Human carcinoma-associated antigen and antibody binding to the antigen
FI942883A FI942883A (fi) 1987-04-03 1994-06-16 Menetelmä ihmisen kasvaimeen liittyvän antigeenin ja sen vasta-aineen valmistamiseksi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK169987A DK169987D0 (da) 1987-04-03 1987-04-03 Human tumor-associated antigen, ca-ou1

Publications (1)

Publication Number Publication Date
DK169987D0 true DK169987D0 (da) 1987-04-03

Family

ID=8107312

Family Applications (1)

Application Number Title Priority Date Filing Date
DK169987A DK169987D0 (da) 1987-04-03 1987-04-03 Human tumor-associated antigen, ca-ou1

Country Status (14)

Country Link
US (1) US5338661A (de)
EP (1) EP0285173B1 (de)
JP (1) JPH082920B2 (de)
KR (1) KR890700358A (de)
AU (1) AU618260B2 (de)
DE (1) DE3884646T2 (de)
DK (1) DK169987D0 (de)
ES (1) ES2059418T3 (de)
FI (1) FI894650A (de)
IE (1) IE60993B1 (de)
IL (1) IL85955A (de)
NZ (1) NZ224156A (de)
WO (1) WO1988007377A1 (de)
ZA (1) ZA882353B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619226B2 (en) * 1987-09-28 1992-01-23 Children's Hospital Medical Center Human cell lines of epithelial lung adenocarcinoma origin, human proteins and methods
US5118611A (en) * 1988-07-25 1992-06-02 Adeza Biomedical Corporation Adenocarcinoma antigen binding methods and reagents
CA2015862A1 (en) * 1989-05-04 1990-11-04 Gajanan Nilaver Cell surface antigen that binds with l6 monoclonal antibody
CA2128700A1 (en) 1992-01-29 1993-08-05 Keiji Koda Carcinoma associated antigen (sk1) and monoclonal antibodies against sk1, methods of producing these antibodies and use therefor
US5834215A (en) * 1994-10-05 1998-11-10 The Administrators Of The Tulane Educational Fund Method for detecting antipolymer antibodies and diagnosing silicone related disease (SRD) fibromyalgia and chronic fatigue syndrome (CFS)
US5744585A (en) * 1995-03-16 1998-04-28 Medenica; Rajko D. Human monoclonal antibody against lung carcinoma
AU4094297A (en) * 1996-08-30 1998-03-19 Auburn University Monoclonal antibodies specific to cooked meats
US6288215B1 (en) 1996-08-30 2001-09-11 Auburn University Monoclonal antibodies specific to cooked meats
US20020127584A1 (en) * 1997-09-18 2002-09-12 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
ATE484522T1 (de) * 2001-04-24 2010-10-15 Bayer Corp Menschliche antikörper gegen timp-1
AU2002327704A1 (en) * 2001-09-21 2003-04-01 Raven Biotechnologies, Inc. Antibodies that bind to cancer-associated antigen cytokeratin 8 and methods of use thereof
AU2003207459A1 (en) * 2002-01-03 2003-07-24 The Scripps Research Institute Cancer-associated epitope

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
GR850552B (de) * 1984-03-07 1985-07-05 Du Pont
US4761377A (en) * 1984-10-15 1988-08-02 The Regents Of The University Of California Human-human hybrid cell lines that produce antibodies against antigenic determinants on cancer cells
ES8800604A1 (es) * 1985-04-22 1987-11-16 Hybritech Inc Un metodo para producir anticuerpos monoclonales
DK172686A (da) * 1985-04-22 1986-10-23 Hybritech Inc Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
AU7144787A (en) * 1986-04-17 1987-10-22 Hybritech Inc. Tumor-associated antigen (mol wt 68,000-48000; 40,000-80000; 28000-32000; 16000-19000)

Also Published As

Publication number Publication date
ZA882353B (en) 1988-09-23
EP0285173A3 (en) 1990-01-31
EP0285173A2 (de) 1988-10-05
JPH02503383A (ja) 1990-10-18
DE3884646D1 (de) 1993-11-11
DE3884646T2 (de) 1994-01-27
KR890700358A (ko) 1989-04-24
EP0285173B1 (de) 1993-10-06
JPH082920B2 (ja) 1996-01-17
US5338661A (en) 1994-08-16
FI894650A0 (fi) 1989-10-02
AU1596588A (en) 1988-11-02
IL85955A (en) 1994-12-29
IE60993B1 (en) 1994-09-07
IL85955A0 (en) 1988-09-30
WO1988007377A1 (en) 1988-10-06
AU618260B2 (en) 1991-12-19
FI894650A (fi) 1989-10-02
ES2059418T3 (es) 1994-11-16
IE880976L (en) 1988-10-03
NZ224156A (en) 1991-07-26

Similar Documents

Publication Publication Date Title
NO880395L (no) Antigener.
DE3883899T2 (de) Geänderte antikörper.
DE3876469T2 (de) Hautaequivalent.
FI883757A0 (fi) Terapeutiska nukleosider.
DE3860192D1 (de) Enthaarungsgeraet.
DE3879452T2 (de) Chimaere antikoerper.
FI881651A (fi) Terapeutiska nukleosider.
DE3789807T2 (de) Kosmetikum.
FI913787A0 (fi) Papiljott.
DK169987D0 (da) Human tumor-associated antigen, ca-ou1
FI902973A0 (fi) Magnetfaeltsgenerator foer terapeutiska aendamaol.
DK190889A (da) Antigen
DE58906056D1 (de) Lockenwickler.
FI881216A (fi) Terapeutiska nukleosider.
FI885968A (fi) Haerdbara blandningar.
MA21243A1 (fr) Shampooing doux .
NO885392L (no) Humant tumor-assosiert antigen.
DK182188D0 (da) Humant tumorassocieret antigen
FI862244A0 (fi) Foerfarande foer bestaemning av antigen.
FI873029A0 (fi) Propp.
NO162876C (no) Sammenleggbar trapp.
DK175091D0 (da) Human tumor associated antigens, ca-ou2 and ca-ou3
NO900681D0 (no) Permrygg.
ES1008013Y (es) Bigudi.
ATE94171T1 (de) Geaenderte antikoerper.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
B1 Patent granted (law 1993)
PPF Opposition filed